Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cyclerion Therapeutics (CYCN) Other Non Operating Income (2023 - 2025)

Cyclerion Therapeutics (CYCN) has 3 years of Other Non Operating Income data on record, last reported at $30000.0 in Q3 2025.

  • For Q3 2025, Other Non Operating Income fell 28.57% year-over-year to $30000.0; the TTM value through Sep 2025 reached $117000.0, down 59.23%, while the annual FY2024 figure was $208000.0, 41.9% down from the prior year.
  • Other Non Operating Income reached $30000.0 in Q3 2025 per CYCN's latest filing, down from $31000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $107000.0 in Q3 2023 and bottomed at $28000.0 in Q4 2024.
  • Average Other Non Operating Income over 3 years is $50500.0, with a median of $36500.0 recorded in 2024.
  • The widest YoY moves for Other Non Operating Income: up 28.57% in 2025, down 63.16% in 2025.
  • A 3-year view of Other Non Operating Income shows it stood at $107000.0 in 2023, then tumbled by 73.83% to $28000.0 in 2024, then rose by 7.14% to $30000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Other Non Operating Income were $30000.0 in Q3 2025, $31000.0 in Q2 2025, and $28000.0 in Q1 2025.